ZOLL MEDICAL CORPORATION

CIK:0000887568|SEC Filings

Comprehensive Income (Tables)

3 Months Ended

Jan. 01, 2012

Schedule Of Total Comprehensive Income (Loss)


	Three Months Ended
(000's omitted)	January 1, 2012			January 2, 2011
Net income	$	6,627		$	3,903
Unrealized loss on available-for-sale securities		(7	)		(6	)
Unrealized gain on derivative instruments		229			10
Foreign currency translation adjustment		482			280

Total comprehensive income	$	7,331		$	4,187

Condensed Consolidated Statements Of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Jan. 01, 2012	Jan. 02, 2011
OPERATING ACTIVITIES:
Net income	$ 6,627	$ 3,903
Charges not affecting cash:
Depreciation and amortization	6,936	6,621
Stock-based compensation expense	1,241	1,047
Changes in current assets and liabilities:
Accounts receivable	17,286	3,580
Inventories	(4,183)	(2,306)
Prepaid expenses and other current assets	(707)	(723)
Accounts payable and accrued expenses	(5,714)	2,541
Cash provided by operating activities	21,486	14,663
INVESTING ACTIVITIES:
Sales of marketable securities		1,541
Purchase of marketable securities	(2,425)
Additions to property and equipment	(17,294)	(7,842)
Payment of contingent consideration related to prior years' acquisitions	(25)	(25)
Other assets, net	(888)	(21)
Cash used for investing activities	(20,632)	(6,347)
FINANCING ACTIVITIES:
Exercise of stock options	39	1,840
Stock option tax benefit	453
Repurchase of common shares	(1,254)
Cash (used for) provided by financing activities	(762)	1,840
Effect of exchange rates on cash and cash equivalents	(68)	165
Net increase in cash and cash equivalents	24	10,321
Cash and cash equivalents at beginning of period	74,161	59,058
Cash and cash equivalents at end of period	74,185	69,379
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Income taxes	$ 1,294	$ 761

Condensed Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Jan. 01, 2012	Oct. 02, 2011
Current assets:
Cash and cash equivalents	$ 74,185	$ 74,161
Marketable securities	3,743	1,318
Accounts receivable, less allowances of $10,880 and $10,269 at January 1, 2012 and October 2, 2011, respectively	101,487	118,691
Inventories:
Raw materials	23,710	22,509
Work-in-process	5,815	6,211
Finished goods	27,149	23,218
Inventory, net	56,674	51,938
Prepaid expenses and other current assets	26,666	25,971
Total current assets	262,755	272,079
Property and equipment at cost:
Land, building and improvements	13,987	3,294
Machinery and equipment	85,254	83,748
Rental equipment	63,446	57,973
Construction in progress	16,696	18,280
Tooling	20,889	20,656
Furniture and fixtures	5,444	5,401
Leasehold improvements	7,923	7,845
Property and equipment, gross	213,639	197,197
Less accumulated depreciation and amortization	120,360	115,815
Net property and equipment	93,279	81,382
Investments	1,310	1,310
Notes receivable	2,019	2,201
Goodwill	79,086	79,086
Intangibles and other assets, net	37,956	38,425
Total assets	476,405	474,483
Current liabilities:
Accounts payable	21,895	24,153
Deferred revenue	20,602	21,808
Accrued expenses and other liabilities	33,951	36,326
Total current liabilities	76,448	82,287
Non-Current liabilities:
Other long-term liabilities	30,038	30,087
Total liabilities	106,486	112,374
Commitments and contingencies (Notes 8 and 14)
Stockholders' equity:
Preferred stock, $0.01 par value, authorized 1,000 shares, none issued or outstanding
Common stock, $0.01 par value, authorized 38,000 shares, 22,054 and 22,080 issued and outstanding at January 1, 2012 and October 2, 2011, respectively	221	221
Capital in excess of par value	191,276	189,780
Accumulated other comprehensive loss	(6,653)	(7,357)
Retained earnings	185,075	179,465
Total stockholders' equity	369,919	362,109
Total liabilities and stockholders' equity	$ 476,405	$ 474,483